UNIVERSITE DE STRASBOURG;INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE)
发明人:
MARION, VINCENT
申请号：
CA3085526
公开号：
CA3085526A1
申请日:
2018.12.14
申请国别(地区):
CA
年份:
2019
代理人:
摘要：
The present invention relates to peptides for the treatment or prevention of nonalcoholic fatty liver disease (NAFLD), non-alcoholic fatty liver (NAFL), non-alcoholic steatohepatitis (NASH), hepatic steatosis (fatty liver), liver inflammation, cirrhosis, hepatocellular carcinoma or fibrosis, especially liver fibrosis.
